Welch Allyn Connex Spot Monitor blood pressure cuffs undeclared natural rubber
Baxter Healthcare is recalling certain Welch Allyn Connex Spot Monitor reusable blood pressure cuffs worldwide because packaging contains an undeclared natural rubber band that may trigger allergic reactions in sensitive individuals.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with an allergen hazard. No illnesses or injuries have been reported in the source text. The hazard is limited to individuals with latex sensitivity, making this a labeling/undeclared allergen issue rather than a widespread safety crisis.
Plain-English summary
Baxter Healthcare Corporation is recalling certain configurations of the Welch Allyn Connex Spot Monitor reusable blood pressure cuffs due to the presence of an undeclared natural rubber band within the packaging. The undeclared rubber presents a potential allergen hazard to consumers with natural rubber latex sensitivity.
The affected product is distributed worldwide. Approximately 70,627 units are involved in the recall across 23 product code/part numbers, with lot number 24-314 and lower. Affected models include variants designated with part numbers such as 73WT-B, 74CE-B, 74CT-B, 74CX-B, and others through 75WT-B.
Consumers who have purchased affected units and have a known or suspected natural rubber latex allergy should stop using the product and contact Baxter Healthcare Corporation for instructions on return or replacement. Those without latex sensitivity may continue normal use. Consumers with questions should reach out to the manufacturer directly.
The recalled product
- Product
- Welch Allyn Welch Allyn Connex Spot Monitor, Product Code/ Part Numbers: 1) 73WT-B; 2) 74CE-B; 3) 74CT-B; 4) 74CX-B; 5) 74ME-B; 6) 74MT-B; 7) 74MX-B; 8) 74RE-B; 9) 74RT-B; 10) 75CE-B; 11) 75CT-B; 12) 75CT-BR; 13) 75CX-B; 14) 75-HCA-CTB; 15) 75-HCA-M
- Manufacturer
- Baxter Healthcare Corporation
- Affected units
- 70,627
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 1) Product Code/Part # 73WT-B
- UDI/DI 00732094210033
- 2) Product Code/Part # 74CE-B
- UDI/DI 00732094209921
- 3) Product Code/Part # 74CT-B
- UDI/DI 00732094209860
- 4) Product Code/Part # 74CX-B
- UDI/DI 00732094209792
- 5) Product Code/Part # 74ME-B
- UDI/DI 00732094209716
- 6) Product Code/Part # 74MT-B
- UDI/DI 00732094209679
- 7) Product Code/Part # 74MX-B
- UDI/DI 00732094209624
- 8) Product Code/Part # 74RE-B
- UDI/DI 00732094335781
- 9) Product Code/Part # 74RT-B
- UDI/DI 00732094335712
- 10) Product Code/Part # 75CE-B
- UDI/DI 00732094209570
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 7 recalled by Baxter Healthcare Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09